In vivo imaging using bioluminescence: A tool for probing graft-versus-host disease

Nature Reviews Immunology

Volumn 6, Issue 6, 2006, Pages 484-490

  Negrin, Robert S ^a   Contag, Christopher H ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; IMMUNOSUPPRESSIVE AGENT; LUCIFERASE; TRACER;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; BIOLUMINESCENCE; BONE MARROW; CARDIAC GRAFT REJECTION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DOG; FLUORESCENCE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMAGING; IMMUNE FUNCTION TEST; IMMUNITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LYMPH NODE IRRADIATION; MORBIDITY; MORTALITY; MOUSE STRAIN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT STRAIN; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSGENIC MOUSE; ULTRASOUND;

ANIMALS; CELL MOVEMENT; GRAFT VS HOST DISEASE; LUMINESCENT PROTEINS; MICROSCOPY, VIDEO;

EID: 33745698850     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1879     Document Type: Review

References (60)

1. Negrin, R. S. & Blume, K. in Williams Hematology 7th edn Ch. 22 (eds Lichtman, M. A. et al.) 209-247 (McGraw-Hill Professional, 2005).
2. Ferrara, J. L. & Deeg, H. J. Graft-versus-host disease. N. Engl. J. Med. 324, 667-674 (1991).
3. Kaitin, K. I. Graft-versus-host disease. N. Engl. J. Med. 325, 357-358 (1991).
4. Sykes, M. & Nikolic, B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435, 620-627 (2005).
5. Thomas, E. D., Storb, R. & Clift, R. A. Bone-marrow transplantation. N. Engl. J. Med. 292, 832-843 (1975).
6. Thomas, E. D., Storb, R. & Clift, R. A. Bone-marrow transplantation. N. Engl. J. Med. 292, 895-902 (1975).
7. Storb, R. et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 94, 2523-2529 (1999).
8. McSweeney, P. A. et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97, 3390-3400 (2001).
9. Lowsky, R. et al. Protective conditioning for acute graft-versus-host disease. N. Engl. J. Med. 353, 1321-1331 (2005).
10. Wu, Y. L. et al. In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. Proc. Natl Acad. Sci. USA 103, 1852-1857 (2006).
11. Sumen, C., Mempel, T. R., Mazo, I. B. & von Andrian, U. H. Intravital microscopy: visualizing immunity in context. Immunity 21, 315-329 (2004).
12. Contag, C. H. et al. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18, 593-603 (1995).
13. Contag, C. et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem. Photobiol. 66, 523-531 (1997).
14. Lipshutz, G. S., Flebbe-Rehwaldt, L. & Gaensler, K. M. Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration. Mol. Ther. 2, 374-380 (2000).
15. Sweeney, T. J. et al. Visualizing the kinetics of tumor cell clearance in living animals. Proc. Natl Acad. Sci. USA 96, 12044-12049 (1999).
16. Massoud, T. F., Paulmurugan, R. & Gambhir, S. S. Molecular imaging of homodimeric protein-protein interactions in living subjects. FASEB J. 18, 1105-1107 (2005).
17. Cao, Y. A. et al. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc. Natl Acad. Sci. USA 101, 221-226 (2004).
18. Jobsis, F. F. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 198, 1264-1267 (1977).
19. Zhao, H. et al. Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J. Biomed. Opt. 10, 41210 (2005).
20. Lipshutz, G. S. et al. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol. Ther. 3, 284-292 (2001).
21. Rehemtulla, A. et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2, 491-495 (2000).
22. Zhao, H. et al. Characterization of coelenterazine analogs for measurements of Renilla luciferase activity in live cells and living animals. Mol. Imaging 3, 43-54 (2004).
23. Bhaumik, S. & Gambhir, S. S. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc. Natl Acad. Sci. USA 99, 377-382 (2002).
24. Edinger, M. et al. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence. Blood 101, 640-648 (2003).
25. Beilhack, A. et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 106, 1113-1122 (2005).
26. Wang, X. et al. Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood 102, 3478-3482 (2003).
27. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature Med. 9, 1144-1150 (2003).
28. Panoskaltsis-Mortari, A. et al. In vivo imaging of graft-versus-host- disease in mice. Blood 103, 3590-3598 (2004).
29. Murakami, T. et al. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J. Exp. Med. 198, 1337-1347 (2003).
30. Murai, M. et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nature Immunol. 4, 154-160 (2003).
31. Welniak, L. A. et al. Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation. Blood 107, 410-412 (2005).
32. Mora, J. R. et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424, 88-93 (2003).
33. + T cells do not induce graft-versus-host disease. J. Clin. Invest. 112, 101-108 (2003).
34. + naive T cells: potential for adoptive immunotherapy and allodepletion. Blood 104, 2403-2409 (2004).
35. 7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft versus host disease. Blood 106, 4009-4015 (2005).
36. Rooney, C. M. et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92, 1549-1555 (1998).
37. + natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production. Blood 97, 2923-2931 (2001).
38. Asai, O. et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J. Clin. Invest. 101, 1835-1842 (1998).
39. Ruggeri, L. et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097-2100 (2002).
40. Miller, J. S. et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105, 3051-3057 (2005).
41. + T lymphocytes. Science 268, 863-865 (1995).
42. Lan, F., Zeng, D., Higuchi, M., Higgins, J. P. & Strober, S. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. Biol. Blood Marrow Transplant. 9, 355-363 (2003).
43. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
44. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196, 389-399 (2002).
45. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493-3499 (2002).
46. + immunoregulatory T cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196, 401-406 (2002).
47. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest 112, 1688-1696 (2003).
48. + regulatory T cells protects from lethal acute GVHD. Blood 105, 2220-2226 (2005).
49. Herschman, H. R. Molecular imaging: looking at problems, seeing solutions. Science 302, 605-608 (2003).
50. Ponomarev, V. et al. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia 3, 480-488 (2001).
51. Dubey, P. et al. Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc. Natl Acad. Sci. USA 100, 1232-1237 (2003).
52. 111In-labeled T-lymphocyte homing in experimental colitis. J. Nucl. Med. 45, 1759-1765 (2004).
53. Bulte, J. W. & Kraitchman, D. L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17, 484-499 (2004).
54. McCaffrey, A., Kay, M. A. & Contag, C. H. Advancing molecular therapies through in vivo bioluminescent imaging. Mol. Imaging 2, 75-86 (2003).
55. Contag, C. H. & Ross, B. D. It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J. Magn. Reson. Imaging 16, 378-387 (2002).
56. Ntziachristos, V., Ripoll, J., Wang, L. V. & Weissleder, R. Looking and listening to light: the evolution of whole-body photonic imaging. Nature Biotechnol. 23, 313-320 (2005).
57. Hildebrandt, I. J. & Gambhir, S. S. Molecular imaging applications for immunology. Clin. Immunol. 111, 210-224 (2004).
58. Contag, C. H. & Bachmann, M. H. Advances in in vivo bioluminescence imaging of gene expression. Annu. Rev. Biomed. Eng. 4, 235-260 (2002).
59. Rice, B. W., Cable, M. D. & Nelson, M. B. In vivo imaging of light-emitting probes. J. Biomed. Opt. 6, 432-440 (2001).
60. Troy, T., Jekic-McMullen, D., Sambucetti, L. & Rice, B. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol. Imaging 3, 9-23 (2004).